Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. (Q48312545)

10 February 2018

title

Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. (English)

1 reference

10 February 2018

1 reference

Morita K

1

1 reference

10 February 2018

Ishimura K

series ordinal

2

1 reference

10 February 2018

Tsuruo Y

series ordinal

3

1 reference

10 February 2018

Wong DL

series ordinal

4

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 January 1999

1 reference

10 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

10 February 2018

volume

816

1 reference

10 February 2018

issue

2

1 reference

10 February 2018

page(s)

309-316

1 reference

10 February 2018

Dexamethasone aggravates ischemia-induced neuronal damage by facilitating the onset of anoxic depolarization and the increase in the intracellular Ca2+ concentration in gerbil hippocampus.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Identification of a collagen potentiated neurite promoting factor isolated from C6 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Adaptation of C6 glioma cells to serum-free conditions leads to the expression of a mixed astrocyte-oligodendrocyte phenotype and increased production of neurite-promoting activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Corticosterone impairs hippocampal neuronal calcium regulation--possible mediating mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Application of the neutral red assay (NR assay) to monolayer cultures of primary hepatocytes: rapid colorimetric viability determination for the unscheduled DNA synthesis test (UDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

RU-26988—a New Tool for the Study of the Mineralocorticoid Receptor*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Cyclic AMP-dependent protein kinase modulation of the glucocorticoid-induced cytolytic response in murine T-lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Platelet-activating factor increases glutamine synthetase activity in early and late passage C-6 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Chronic dexamethasone pretreatment aggravates ischemic neuronal necrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Maintenance of glial plasticity with aging in C-6 glial cells and normal astrocytes in culture: responsiveness to opioid peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Hippocampal aging and adrenocorticoids: quantitative correlations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Adrenal steroid receptors and actions in the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Regulation of ischemic hippocampal damage in the gerbil: adrenalectomy alters the rate of CA1 cell disappearance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Attenuation of neurotoxicity following anoxia or glutamate receptor activation in EGF- and hippocampal extract-treated neuronal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoid Stimulation of Glutamine Synthetase Production in Cultured Rat Glioma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Steroid hormone receptors and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoid toxicity in the hippocampus: temporal aspects of neuronal vulnerability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

A mechanism for glucocorticoid toxicity in the hippocampus: increased neuronal vulnerability to metabolic insults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoid toxicity in the hippocampus. Temporal aspects of synergy with kainic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoid toxicity in the hippocampus: in vitro demonstration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoids exacerbate hypoxic and hypoglycemic hippocampal injury in vitro: biochemical correlates and a role for astrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

DNA fragmentation in S49 lymphoma cells killed with glucocorticoids and other agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Astrocytes protect cultured neurons from degeneration induced by anoxia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Glucocorticoids Inhibit Glucose Transport and Glutamate Uptake in Hippocampal Astrocytes: Implications for Glucocorticoid Neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

Neuronotrophic factors released by C6 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2901093-2

10.1016/S0006-8993(98)01093-2

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9878804

1 reference

10 February 2018